{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T19:01:34Z","timestamp":1790708494958,"version":"4.1.0"},"reference-count":151,"publisher":"MDPI AG","issue":"3","license":[{"start":{"date-parts":[[2022,3,3]],"date-time":"2022-03-03T00:00:00Z","timestamp":1646265600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Vaccines"],"abstract":"<jats:p>The genus mycobacterium includes several species that are known to cause infections in humans. The microorganisms are classified into tuberculous and non-tuberculous based on their morphological characteristics, defined by the dynamic relationship between the host defenses and the infectious agent. Non-tuberculous mycobacteria (NTM) include all the species of mycobacterium other than the ones that cause tuberculosis (TB). The group of NTM contains almost 200 different species and they are found in soil, water, animals\u2014both domestic and wild\u2014milk and food products, and from plumbed water resources such as sewers and showerhead sprays. A systematic review of Medline between 1946 and 2014 showed an 81% decline in TB incidence rates with a simultaneous 94% increase in infections caused by NTM. Prevalence of infections due to NTM has increased relative to infections caused by TB owing to the stringent prevention and control programs in Western countries such as the USA and Canada. While the spread of typical mycobacterial infections such as TB and leprosy involves human contact, NTM seem to spread easily from the environment without the risk of acquiring from a human contact except in the case of M. abscessus in patients with cystic fibrosis, where human transmission as well as transmission through fomites and aerosols has been recorded. NTM are opportunistic in their infectious processes, making immunocompromised individuals such as those with other systemic infections such as HIV, immunodeficiencies, pulmonary disease, or usage of medications such as long-term corticosteroids\/TNF-\u03b1 inhibitors more susceptible. This review provides insight on pathogenesis, treatment, and BCG vaccine efficacy against M. leprae and some important NTM infections.<\/jats:p>","DOI":"10.3390\/vaccines10030390","type":"journal-article","created":{"date-parts":[[2022,3,3]],"date-time":"2022-03-03T20:36:30Z","timestamp":1646339790000},"page":"390","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":26,"title":["Protective Efficacy of BCG Vaccine against Mycobacterium leprae and Non-Tuberculous Mycobacterial Infections"],"prefix":"10.3390","volume":"10","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-6184-3624","authenticated-orcid":false,"given":"Davit","family":"Orujyan","sequence":"first","affiliation":[{"name":"College of Osteopathic Medicine of the Pacific, Western University of Health Sciences, Pomona, CA 91766, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0120-4289","authenticated-orcid":false,"given":"William","family":"Narinyan","sequence":"additional","affiliation":[{"name":"College of Osteopathic Medicine of the Pacific, Western University of Health Sciences, Pomona, CA 91766, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Subhapradha","family":"Rangarajan","sequence":"additional","affiliation":[{"name":"College of Osteopathic Medicine of the Pacific, Western University of Health Sciences, Pomona, CA 91766, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patrida","family":"Rangchaikul","sequence":"additional","affiliation":[{"name":"College of Osteopathic Medicine of the Pacific, Western University of Health Sciences, Pomona, CA 91766, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chaya","family":"Prasad","sequence":"additional","affiliation":[{"name":"College of Osteopathic Medicine of the Pacific, Western University of Health Sciences, Pomona, CA 91766, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Beatrice","family":"Saviola","sequence":"additional","affiliation":[{"name":"College of Osteopathic Medicine of the Pacific, Western University of Health Sciences, Pomona, CA 91766, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2586-1160","authenticated-orcid":false,"given":"Vishwanath","family":"Venketaraman","sequence":"additional","affiliation":[{"name":"College of Osteopathic Medicine of the Pacific, Western University of Health Sciences, Pomona, CA 91766, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2022,3,3]]},"reference":[{"key":"ref_1","unstructured":"CDC (2021, July 08). Diseases and Organisms in Healthcare Settings, Available online: https:\/\/www.cdc.gov\/hai\/organisms\/nontuberculous-mycobacteria.html."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1016\/j.abd.2021.04.005","article-title":"Non-tuberculous cutaneous mycobacterioses","volume":"96","author":"Nogueira","year":"2021","journal-title":"An. Bras. Dermatol."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1007\/5584_2016_45","article-title":"Non-Tuberculous Mycobacteria: Classification, Diagnostics, and Therapy","volume":"944","author":"Porvaznik","year":"2017","journal-title":"Adv. Exp. Med. Biol."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"809014","DOI":"10.1155\/2015\/809014","article-title":"General Overview on Nontuberculous Mycobacteria, Biofilms, and Human Infection","volume":"2015","author":"Faria","year":"2015","journal-title":"J. Pathog."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"1370","DOI":"10.5588\/ijtld.14.0120","article-title":"The epidemiologic relationship between tuberculosis and non-tuberculous mycobacterial disease: A systematic review","volume":"18","author":"Brode","year":"2014","journal-title":"Int. J. Tuberc. Lung Dis."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1007\/s10096-012-1766-8","article-title":"Clinical and laboratory aspects of the diagnosis and management of cutaneous and subcutaneous infections caused by rapidly growing mycobacteria","volume":"32","author":"Kothavade","year":"2012","journal-title":"Eur. J. Clin. Microbiol."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"2029","DOI":"10.3389\/fmicb.2018.02029","article-title":"Global Environmental Nontuberculous Mycobacteria and Their Contemporaneous Man-Made and Natural Niches","volume":"9","author":"Honda","year":"2018","journal-title":"Front. Microbiol."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"968","DOI":"10.1016\/S1473-3099(15)00089-4","article-title":"Host susceptibility to non-tuberculous mycobacterial infections","volume":"15","author":"Wu","year":"2015","journal-title":"Lancet Infect. Dis."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"116","DOI":"10.3389\/fmicb.2020.00116","article-title":"Differential Responses by Human Macrophages to Infection With Mycobacterium tuberculosis and Non-tuberculous Mycobacteria","volume":"11","author":"Feng","year":"2020","journal-title":"Front. Microbiol."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"e2","DOI":"10.1016\/S1473-3099(21)00403-5","article-title":"100 years of Mycobacterium bovis bacille Calmette-Gu\u00e9rin","volume":"22","author":"Lange","year":"2022","journal-title":"Lancet Infect. Dis."},{"key":"ref_11","first-page":"53","article-title":"History of BCG Vaccine","volume":"8","author":"Luca","year":"2013","journal-title":"Maedica"},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1016\/S0962-8479(05)80028-0","article-title":"Atypical mycobacteria in extrapulmonary disease among children. Incidence in Sweden from 1969 to 1990, related to changing BCG-vaccination coverage","volume":"76","author":"Romanus","year":"1995","journal-title":"Tuber. Lung Dis."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1016\/0041-3879(87)90070-5","article-title":"Neonatal bcg vaccination and mycobacterial cervical adenitis in childhood","volume":"68","author":"Katila","year":"1987","journal-title":"Tubercle"},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"491","DOI":"10.5588\/ijtld.18.0336","article-title":"Prevalence of non-tuberculous mycobacteria in HIV-infected patients admitted to hospital with pneumonia","volume":"23","author":"Lapinel","year":"2019","journal-title":"Int. J. Tuberc. Lung Dis."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"628","DOI":"10.4269\/ajtmh.20-0973","article-title":"Prevalence of Nontuberculous Mycobacterium Infections versus Tuberculosis among Autopsied HIV Patients in Sub-Saharan Africa: A Systematic Review and Meta-Analysis","volume":"104","author":"Chiang","year":"2021","journal-title":"Am. J. Trop. Med. Hyg."},{"key":"ref_16","first-page":"150","article-title":"Potential role of Bacillus Calmette-Gu\u00e9rin (BCG) vaccination in COVID-19 pandemic mortality: Epidemiological and Immunological aspects","volume":"38","author":"Charoenlap","year":"2020","journal-title":"Asian Pac. J. Allergy Immunol."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1136\/bmj.2.6082.293","article-title":"BCG and vole bacillus vaccines in the prevention of tuberculosis in adolescence and early adult life","volume":"2","author":"Hart","year":"1977","journal-title":"BMJ"},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"583","DOI":"10.2307\/4590872","article-title":"Controlled Trial of BCG Vaccination in a School Population: Tuberculosis Studies in Muscogee County, Ga","volume":"75","author":"Comstock","year":"1960","journal-title":"Public Health Rep."},{"key":"ref_19","first-page":"839","article-title":"Tuberculosis studies in Muscogee County, Georgia. VII. A twenty-year evaluation of BCG vaccination in a school population","volume":"100","author":"Comstock","year":"1969","journal-title":"Am. Rev. Respir. Dis."},{"key":"ref_20","first-page":"171","article-title":"Long-term results of BCG vaccination in the southern United States","volume":"93","author":"Comstock","year":"1966","journal-title":"Am. Rev. Respir. Dis."},{"key":"ref_21","first-page":"276","article-title":"Tuberculosis studies in Muscogee County, Georgia. Twenty-year evaluation of a community trial of BCG vaccination","volume":"91","author":"Comstock","year":"1976","journal-title":"Public Health Rep."},{"key":"ref_22","first-page":"207","article-title":"An American view of BCG vaccination, illustrated by results of a controlled trial in Puerto Rico","volume":"53","author":"Comstock","year":"1972","journal-title":"Scand. J. Respir. Dis."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"283","DOI":"10.2105\/AJPH.64.3.283","article-title":"Evaluation of BCG vaccination among Puerto Rican children","volume":"64","author":"Comstock","year":"1974","journal-title":"Am. J. Public Health"},{"key":"ref_24","first-page":"553","article-title":"Effects of infection with atypical mycobacteria on BCG vaccination and tuberculosis","volume":"94","author":"Palmer","year":"1966","journal-title":"Am. Rev. Respir. Dis."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"1339","DOI":"10.1016\/S0140-6736(95)92348-9","article-title":"Variation in protection by BCG: Implications of and for heterologous immunity","volume":"346","author":"Fine","year":"1995","journal-title":"Lancet"},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"982","DOI":"10.1093\/clinids\/20.4.982","article-title":"Geographic Latitude and the Efficacy of Bacillus Calmette-Guerin Vaccine","volume":"20","author":"Wilson","year":"1995","journal-title":"Clin. Infect. Dis."},{"key":"ref_27","first-page":"205","article-title":"The geographic location (latitude) of studies evaluating protective effect of BCG vaccine and it\u2019s efficacy\/effectiveness against tuberculosis","volume":"51","author":"Zodpey","year":"2007","journal-title":"Indian J. Public Health"},{"key":"ref_28","unstructured":"Tuberculosis Prevention TRIAL (1979). Trial of BCG vaccines in south India for tuberculosis prevention: First report\u2014Tuberculosis Prevention Trial. Bull. World Health Organ., 57, 819\u2013827."},{"key":"ref_29","unstructured":"Tuberculois Research Centre (2013). Fifteen year follow up of trial of BCG vaccines in south India for tuberculosis prevention. Indian J. Med. Res., 137, 571."},{"key":"ref_30","first-page":"836","article-title":"The cytokine response to bacille Calmette Gu\u00e9rin vaccination in South India","volume":"2","author":"Das","year":"1998","journal-title":"Int. J. Tuberc. Lung Dis."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1111\/j.1574-695X.2012.01002.x","article-title":"Purified protein derivatives of tuberculin\u2014past, present, and future","volume":"66","author":"Yang","year":"2012","journal-title":"FEMS Immunol. Med. Microbiol."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1136\/vr.c3403","article-title":"Comparison of tuberculin activity using the interferon-gamma assay for the diagnosis of bovine tuberculosis","volume":"167","author":"Schiller","year":"2010","journal-title":"Vet. Rec."},{"key":"ref_33","doi-asserted-by":"crossref","unstructured":"Flores-Valdez, M.A. (2021). After 100 Years of BCG Immunization against Tuberculosis, What Is New and Still Outstanding for This Vaccine?. Vaccines, 10.","DOI":"10.3390\/vaccines10010057"},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"1134","DOI":"10.3389\/fimmu.2017.01134","article-title":"What Have We Learnt about BCG Vaccination in the Last 20 Years?","volume":"8","author":"Dockrell","year":"2017","journal-title":"Front. Immunol."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1016\/j.tube.2013.12.006","article-title":"Non-tuberculous mycobacteria have diverse effects on BCG efficacy against Mycobacterium tuberculosis","volume":"94","author":"Poyntz","year":"2014","journal-title":"Tuberculosis"},{"key":"ref_36","first-page":"801","article-title":"Leprosy\u2014An overview of clinical features, diagnosis, and treatment","volume":"15","author":"Fischer","year":"2017","journal-title":"JDDG J. Dtsch. Dermatol. Ges."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"e00069-18","DOI":"10.1128\/CMR.00069-18","article-title":"Cutaneous Mycobacterial Infections","volume":"32","author":"Marcos","year":"2018","journal-title":"Clin. Microbiol. Rev."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1590\/abd1806-4841.20142450","article-title":"Leprosy: Review of the epidemiological, clinical, and etiopathogenic aspects\u2014Part 1","volume":"89","author":"Abreu","year":"2014","journal-title":"An. Bras. Dermatol."},{"key":"ref_39","doi-asserted-by":"crossref","unstructured":"Ploemacher, T., Faber, W.R., Menke, H., Rutten, V.P., and Pieters, T. (2020). Reservoirs and transmission routes of leprosy; A systematic review. PLoS Negl. Trop. Dis., 14.","DOI":"10.1371\/journal.pntd.0008276"},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"203","DOI":"10.2165\/00128071-200102040-00001","article-title":"Leprosy: Recognition and treatment","volume":"2","author":"Rebello","year":"2001","journal-title":"Am. J. Clin. Dermatol."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"2645","DOI":"10.1128\/IAI.00147-13","article-title":"Interaction of Mycobacterium leprae with Human Airway Epithelial Cells: Adherence, Entry, Survival, and Identification of Potential Adhesins by Surface Proteome Analysis","volume":"81","author":"Silva","year":"2013","journal-title":"Infect. Immun."},{"key":"ref_42","unstructured":"Bhandari, J., Awais, M., and Gupta, V. (2021). Leprosy. StatPearls, StatPearls Publishing LLC."},{"key":"ref_43","first-page":"79","article-title":"Current approaches and future directions in the treatment of leprosy","volume":"3","author":"Worobec","year":"2012","journal-title":"Res. Rep. Trop. Med."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"181089","DOI":"10.1155\/2012\/181089","article-title":"Leprosy: An Overview of Pathophysiology","volume":"2012","author":"Bhat","year":"2012","journal-title":"Interdiscip. Perspect. Infect. Dis."},{"key":"ref_45","first-page":"255","article-title":"Classification of leprosy according to immunity. A five-group system","volume":"34","author":"Ridley","year":"1966","journal-title":"Int. J. Lepr. Other Mycobact. Dis."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1590\/abd1806-4841.20132004","article-title":"Understanding the type 1 reactional state for early diagnosis and treatment: A way to avoid disability in leprosy","volume":"88","author":"Nery","year":"2013","journal-title":"An. Bras. Dermatol."},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1128\/CMR.19.2.338-381.2006","article-title":"The Continuing Challenges of Leprosy","volume":"19","author":"Scollard","year":"2006","journal-title":"Clin. Microbiol. Rev."},{"key":"ref_48","doi-asserted-by":"crossref","unstructured":"van \u2018t Noordende, A.T., Korfage, I.J., Lisam, S., Arif, M.A., Kumar, A., and van Brakel, W.H. (2019). The role of perceptions and knowledge of leprosy in the elimination of leprosy: A baseline study in Fatehpur district, northern India. PLoS Negl. Trop. Dis., 13.","DOI":"10.1371\/journal.pntd.0007302"},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"2744","DOI":"10.1128\/IAI.73.5.2744-2750.2005","article-title":"Identification of an Immunomodulating Agent from Mycobacterium leprae","volume":"73","author":"Maeda","year":"2005","journal-title":"Infect. Immun."},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"5167","DOI":"10.1128\/IAI.70.9.5167-5176.2002","article-title":"Mycobacterium leprae Infection in Monocyte-Derived Dendritic Cells and Its Influence on Antigen-Presenting Function","volume":"70","author":"Hashimoto","year":"2002","journal-title":"Infect. Immun."},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"217","DOI":"10.2217\/fmb.10.173","article-title":"Mycobacterium leprae\u2013host-cell interactions and genetic determinants in leprosy: An overview","volume":"6","author":"Pinheiro","year":"2011","journal-title":"Futur. Microbiol."},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1128\/IAI.00816-09","article-title":"Mycobacterium leprae actively modulates the cytokine response in naive human monocytes","volume":"78","author":"Sinsimer","year":"2010","journal-title":"Infect. Immun."},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"1841","DOI":"10.1080\/21645515.2019.1706930","article-title":"BCG: A vaccine with multiple faces","volume":"16","author":"Unzueta","year":"2020","journal-title":"Hum. Vaccines Immunother."},{"key":"ref_54","first-page":"97","article-title":"The State of Affairs in Post-Exposure Leprosy Prevention: A Descriptive Meta-Analysis on Immuno- and Chemo-Prophylaxis","volume":"11","author":"Schoenmakers","year":"2020","journal-title":"Res. Rep. Trop. Med."},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1016\/j.ijid.2016.10.018","article-title":"Novel approaches to tuberculosis vaccine development","volume":"56","author":"Kaufmann","year":"2017","journal-title":"Int. J. Infect. Dis."},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/j.abd.2020.08.032","article-title":"Chronic recalcitrant erythema nodosum leprosum: Therapeutic dilemma and role of mycobacterium indicus pranii vaccine","volume":"97","author":"Gupta","year":"2021","journal-title":"An. Bras. Dermatol."},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1016\/j.tube.2016.10.002","article-title":"Mycobacterium indicus pranii as a booster vaccine enhances BCG induced immunity and confers higher protection in animal models of tuberculosis","volume":"101","author":"Saqib","year":"2016","journal-title":"Tuberculosis"},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"2337","DOI":"10.1007\/s13311-021-01153-z","article-title":"Treatment and Evaluation Advances in Leprosy Neuropathy","volume":"18","author":"Ebenezer","year":"2021","journal-title":"Neurotherapeutics"},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"1151","DOI":"10.2217\/fmb.09.87","article-title":"The vitamin D\u2014Antimicrobial peptide pathway and its role in protection against infection","volume":"4","author":"Gombart","year":"2009","journal-title":"Futur. Microbiol."},{"key":"ref_60","doi-asserted-by":"crossref","unstructured":"Zavala, K., Gottlieb, C.A., Teles, R., Adams, J.S., Hewison, M., Modlin, R.L., and Liu, P.T. (2018). Intrinsic activation of the vitamin D antimicrobial pathway by M. leprae infection is inhibited by type I IFN. PLoS Negl. Trop. Dis., 12.","DOI":"10.1371\/journal.pntd.0006815"},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.mam.2008.08.006","article-title":"Glutathione: Overview of its protective roles, measurement, and biosynthesis","volume":"30","author":"Forman","year":"2009","journal-title":"Mol. Asp. Med."},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"321","DOI":"10.4103\/0019-5154.156426","article-title":"Study of oxidative stress in different forms of leprosy","volume":"60","author":"Swathi","year":"2015","journal-title":"Indian J. Dermatol."},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1016\/j.jinf.2008.03.009","article-title":"Erythrocyte glutathione peroxidase, glutathione reductase activities and blood glutathione content in leprosy","volume":"56","author":"Prasad","year":"2008","journal-title":"J. Infect."},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"8416763","DOI":"10.1155\/2017\/8416763","article-title":"Oxidative Stress: Harms and Benefits for Human Health","volume":"2017","author":"Pizzino","year":"2017","journal-title":"Oxid. Med. Cell. Longev."},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/j.tube.2018.12.004","article-title":"Mycobacterium avium: An overview","volume":"114","author":"Busatto","year":"2019","journal-title":"Tuberculosis"},{"key":"ref_66","unstructured":"Akram, S.M., and Attia, F.N. (2021). Mycobacterium Avium Intracellulare. StatPearls, StatPearls Publishing LLC."},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1046\/j.1365-2249.2001.01708.x","article-title":"Comparative protective effects of recombinant DNA and Mycobacterium bovis bacille Calmette-Gu\u00e9rin vaccines against M. avium infection","volume":"126","author":"Martin","year":"2001","journal-title":"Clin. Exp. Immunol."},{"key":"ref_68","doi-asserted-by":"crossref","unstructured":"To, K., Cao, R., Yegiazaryan, A., Owens, J., and Venketaraman, V. (2020). General Overview of Nontuberculous Mycobacteria Opportunistic Pathogens: Mycobacterium avium and Mycobacterium abscessus. J. Clin. Med., 9.","DOI":"10.3390\/jcm9082541"},{"key":"ref_69","doi-asserted-by":"crossref","unstructured":"Munjal, S., Munjal, S., Gao, J., and Venketaraman, V. (2021). Exploring Potential COPD Immunosuppression Pathways Causing Increased Susceptibility for MAC Infections among COPD Patients. Clin. Pract., 11.","DOI":"10.3390\/clinpract11030077"},{"key":"ref_70","first-page":"153","article-title":"Mechanisms of Mycobacterium Avium Pathogenesis","volume":"48","author":"Bermudez","year":"2001","journal-title":"Anxiety Anxiolytic Drugs"},{"key":"ref_71","doi-asserted-by":"crossref","first-page":"303","DOI":"10.3389\/fimmu.2020.00303","article-title":"The Rise of Non-Tuberculosis Mycobacterial Lung Disease","volume":"11","author":"Ratnatunga","year":"2020","journal-title":"Front. Immunol."},{"key":"ref_72","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1111\/imr.12959","article-title":"The double-edged sword of Tregs in M tuberculosis, M avium, and M. absessus infection","volume":"301","author":"Verma","year":"2021","journal-title":"Immunol. Rev."},{"key":"ref_73","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1186\/s12964-016-0152-z","article-title":"The role of IL-10 in Mycobacterium avium subsp. paratuberculosis infection","volume":"14","author":"Hussain","year":"2016","journal-title":"Cell Commun. Signal."},{"key":"ref_74","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1128\/microbiolspec.TNMI7-0024-2016","article-title":"Nontuberculous Mycobacteria\u2014Overview","volume":"5","author":"Koh","year":"2017","journal-title":"Microbiol. Spectr."},{"key":"ref_75","doi-asserted-by":"crossref","unstructured":"Daley, C.L., and Schlossberg, D. (2017). Mycobacterium avium Complex Disease. Microbiol. Spectr., 5.","DOI":"10.1128\/microbiolspec.TNMI7-0045-2017"},{"key":"ref_76","first-page":"E8","article-title":"Primary cutaneous Mycobacterium avium complex infection following squamous cell carcinoma excision","volume":"98","author":"Dyer","year":"2016","journal-title":"Cutis"},{"key":"ref_77","doi-asserted-by":"crossref","unstructured":"Xu, X., Lao, X., Zhang, C., Cao, C., Ding, H., Pang, Y., Ning, Q., Zou, J., Zang, N., and Hu, D. (2019). Chronic Mycobacterium avium skin and soft tissue infection complicated with scalp osteomyelitis possibly secondary to anti-interferon-\u03b3 autoantibody formation. BMC Infect. Dis., 19.","DOI":"10.1186\/s12879-019-3771-3"},{"key":"ref_78","doi-asserted-by":"crossref","first-page":"9040","DOI":"10.1038\/s41598-021-88291-8","article-title":"Subunit vaccine protects against a clinical isolate of Mycobacterium avium in wild type and immunocompromised mouse models","volume":"11","author":"Larsen","year":"2021","journal-title":"Sci. Rep."},{"key":"ref_79","doi-asserted-by":"crossref","first-page":"234","DOI":"10.3389\/fimmu.2019.00234","article-title":"BCG Vaccination Induces M. avium and M. abscessus Cross-Protective Immunity","volume":"10","author":"Abate","year":"2019","journal-title":"Front. Immunol."},{"key":"ref_80","doi-asserted-by":"crossref","first-page":"716","DOI":"10.1128\/CMR.15.4.716-746.2002","article-title":"Clinical and Taxonomic Status of Pathogenic Nonpigmented or Late-Pigmenting Rapidly Growing Mycobacteria","volume":"15","author":"Wallace","year":"2002","journal-title":"Clin. Microbiol. Rev."},{"key":"ref_81","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1038\/s41579-020-0331-1","article-title":"Non-tuberculous mycobacteria and the rise of Mycobacterium abscessus","volume":"18","author":"Johansen","year":"2020","journal-title":"Nat. Rev. Microbiol."},{"key":"ref_82","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1099\/00207713-42-2-240","article-title":"Proposal of Mycobacterium peregrinum sp. nov., nom. rev., and Elevation of Mycobacterium chelonae subsp. abscessus (Kubica et al.) to Species Status: Mycobacterium abscessus comb. nov","volume":"42","author":"Kusunoki","year":"1992","journal-title":"Int. J. Syst. Bacteriol."},{"key":"ref_83","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/j.tim.2009.12.007","article-title":"Mycobacterium abscessus: A new player in the mycobacterial field","volume":"18","author":"Medjahed","year":"2010","journal-title":"Trends Microbiol."},{"key":"ref_84","doi-asserted-by":"crossref","first-page":"2642","DOI":"10.3389\/fmicb.2018.02642","article-title":"Mycobacterium abscessus: Shapeshifter of the Mycobacterial World","volume":"9","author":"Ryan","year":"2018","journal-title":"Front. Microbiol."},{"key":"ref_85","doi-asserted-by":"crossref","first-page":"1581","DOI":"10.1099\/mic.0.28625-0","article-title":"Spontaneous reversion of Mycobacterium abscessus from a smooth to a rough morphotype is associated with reduced expression of glycopeptidolipid and reacquisition of an invasive phenotype","volume":"152","author":"Howard","year":"2006","journal-title":"Microbiology"},{"key":"ref_86","doi-asserted-by":"crossref","first-page":"1187","DOI":"10.1099\/mic.0.046557-0","article-title":"Deletion of the mmpL4b gene in the Mycobacterium abscessus glycopeptidolipid biosynthetic pathway results in loss of surface colonization capability, but enhanced ability to replicate in human macrophages and stimulate their innate immune response","volume":"157","author":"Nessar","year":"2011","journal-title":"Microbiology"},{"key":"ref_87","doi-asserted-by":"crossref","first-page":"1497","DOI":"10.1128\/JCM.02592-06","article-title":"Molecular Epidemiology of Mycobacterium abscessus, with Focus on Cystic Fibrosis","volume":"45","author":"Jonsson","year":"2007","journal-title":"J. Clin. Microbiol."},{"key":"ref_88","doi-asserted-by":"crossref","first-page":"1997","DOI":"10.4049\/jimmunol.0802181","article-title":"Mycobacterium abscessus Glycopeptidolipids Mask Underlying Cell Wall Phosphatidyl-myo-Inositol Mannosides Blocking Induction of Human Macrophage TNF-\u03b1 by Preventing Interaction with TLR2","volume":"183","author":"Rhoades","year":"2009","journal-title":"J. Immunol."},{"key":"ref_89","unstructured":"(2021, November 21). Mycobacterium Abscessus in Healthcare Settings, Available online: https:\/\/www.cdc.gov\/hai\/organisms\/mycobacterium.html."},{"key":"ref_90","doi-asserted-by":"crossref","first-page":"e01782-17","DOI":"10.1128\/AAC.01782-17","article-title":"Mycobacterium abscessus Smooth and Rough Morphotypes Form Antimicrobial-Tolerant Biofilm Phenotypes but Are Killed by Acetic Acid","volume":"62","author":"Clary","year":"2018","journal-title":"Antimicrob. Agents Chemother."},{"key":"ref_91","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1164\/rccm.200604-571ST","article-title":"An Official ATS\/IDSA Statement: Diagnosis, Treatment, and Prevention of Nontuberculous Mycobacterial Diseases","volume":"175","author":"Griffith","year":"2007","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"ref_92","doi-asserted-by":"crossref","first-page":"S26","DOI":"10.1016\/j.ajic.2005.04.002","article-title":"Prevention and control of health care\u2013associated waterborne infections in health care facilities","volume":"33","author":"Exner","year":"2005","journal-title":"Am. J. Infect. Control"},{"key":"ref_93","doi-asserted-by":"crossref","first-page":"1367","DOI":"10.1128\/AAC.01275-08","article-title":"A novel gene, erm(41), confers inducible macrolide resistance to clinical isolates of Mycobacterium abscessus but is absent from Mycobacterium chelonae","volume":"53","author":"Nash","year":"2009","journal-title":"Antimicrob. Agents Chemother."},{"key":"ref_94","doi-asserted-by":"crossref","first-page":"4184","DOI":"10.1128\/AAC.00598-07","article-title":"The Macrolide Resistance Genes erm(B) and mef(E) Are Carried by Tn2010 in Dual-Gene Streptococcus pneumoniae Isolates Belonging to Clonal Complex CC271","volume":"51","author":"Northwood","year":"2007","journal-title":"Antimicrob. Agents Chemother."},{"key":"ref_95","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1007\/s002840010106","article-title":"Specific Inhibition of 50S Ribosomal Subunit Formation in Staphylococcus aureus Cells by 16-Membered Macrolide, Lincosamide, and Streptogramin B Antibiotics","volume":"41","author":"Champney","year":"2000","journal-title":"Curr. Microbiol."},{"key":"ref_96","doi-asserted-by":"crossref","first-page":"1058","DOI":"10.1128\/AAC.33.7.1058","article-title":"Binding of novel macrolide structures to macrolides-lincosamides-streptogramin B-resistant ribosomes inhibits protein synthesis and bacterial growth","volume":"33","author":"Goldman","year":"1989","journal-title":"Antimicrob. Agents Chemother."},{"key":"ref_97","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1016\/j.diagmicrobio.2017.12.008","article-title":"Treatment outcomes of macrolide-susceptible Mycobacterium abscessus lung disease","volume":"90","author":"Choi","year":"2018","journal-title":"Diagn. Microbiol. Infect. Dis."},{"key":"ref_98","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1093\/cid\/ciw724","article-title":"Mycobacterial Characteristics and Treatment Outcomes in Mycobacterium abscessus Lung Disease","volume":"64","author":"Koh","year":"2016","journal-title":"Clin. Infect. Dis."},{"key":"ref_99","doi-asserted-by":"crossref","first-page":"1141","DOI":"10.5588\/ijtld.14.0134","article-title":"Advances in the management of pulmonary disease due to Mycobacterium abscessus complex","volume":"18","author":"Koh","year":"2014","journal-title":"Int. J. Tuberc. Lung Dis."},{"key":"ref_100","doi-asserted-by":"crossref","first-page":"3430","DOI":"10.1128\/JCM.01714-15","article-title":"New Real-Time PCR Assays for Detection of Inducible and Acquired Clarithromycin Resistance in the Mycobacterium abscessus Group","volume":"53","author":"Shallom","year":"2015","journal-title":"J. Clin. Microbiol."},{"key":"ref_101","doi-asserted-by":"crossref","first-page":"1260","DOI":"10.1001\/jama.2013.2290","article-title":"Effect of long-term, low-dose erythromycin on pulmonary exacerbations among patients with non-cystic fibrosis bronchiectasis: The BLESS randomized controlled trial","volume":"309","author":"Serisier","year":"2013","journal-title":"JAMA"},{"key":"ref_102","doi-asserted-by":"crossref","first-page":"1638","DOI":"10.3201\/2109.141634","article-title":"Mycobacterium abscessus Complex Infections in Humans","volume":"21","author":"Lee","year":"2015","journal-title":"Emerg. Infect. Dis."},{"key":"ref_103","doi-asserted-by":"crossref","unstructured":"Meir, M., and Barkan, D. (2020). Alternative and Experimental Therapies of Mycobacterium abscessus Infections. Int. J. Mol. Sci., 21.","DOI":"10.20944\/preprints202008.0273.v1"},{"key":"ref_104","doi-asserted-by":"crossref","first-page":"2095","DOI":"10.3389\/fmicb.2018.02095","article-title":"Tedizolid Activity Against Clinical Mycobacterium abscessus Complex Isolates\u2014An in vitro Characterization Study","volume":"9","author":"Tang","year":"2018","journal-title":"Front. Microbiol."},{"key":"ref_105","unstructured":"Akram, S.M., and Aboobacker, S. (2021). Mycobacterium Marinum. StatPearls, StatPearls Publishing LLC."},{"key":"ref_106","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1684\/ejd.2013.2103","article-title":"Aquarium-borne Mycobacterium marinum skin infection. Report of 15 cases and review of the literature","volume":"23","author":"Bonamonte","year":"2013","journal-title":"Eur. J. Dermatol."},{"key":"ref_107","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1016\/j.dci.2012.07.006","article-title":"Analysis of the immune response in infections of the goldfish (Carassius auratus L.) with Mycobacterium marinum","volume":"38","author":"Hodgkinson","year":"2012","journal-title":"Dev. Comp. Immunol."},{"key":"ref_108","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1080\/01652176.2018.1447171","article-title":"Mycobacterium marinum infection in fish and man: Epidemiology, pathophysiology and management: A review","volume":"38","author":"Hashish","year":"2018","journal-title":"Veter-Q."},{"key":"ref_109","doi-asserted-by":"crossref","first-page":"1027","DOI":"10.1111\/j.1462-5822.2008.01133.x","article-title":"Comparative pathogenesis of Mycobacterium marinum and Mycobacterium tuberculosis","volume":"10","author":"Tobin","year":"2008","journal-title":"Cell. Microbiol."},{"key":"ref_110","doi-asserted-by":"crossref","first-page":"1746","DOI":"10.1001\/archinte.162.15.1746","article-title":"Sixty-three cases of Mycobacterium marinum infection: Clinical features, treatment, and antibiotic susceptibility of causative isolates","volume":"162","author":"Aubry","year":"2002","journal-title":"Arch. Intern. Med."},{"key":"ref_111","doi-asserted-by":"crossref","first-page":"1057","DOI":"10.1128\/jb.86.5.1057-1069.1963","article-title":"effect of environmental temperatures on infection with Mycobacterium marinum (balnei) of Mice and a number of poikilothermic species","volume":"86","author":"Clark","year":"1963","journal-title":"J. Bacteriol."},{"key":"ref_112","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1111\/j.1399-3062.2008.00317.x","article-title":"Mycobacterium marinum infections in transplant recipients: Case report and review of the literature","volume":"10","author":"Pandian","year":"2008","journal-title":"Transpl. Infect. Dis."},{"key":"ref_113","doi-asserted-by":"crossref","unstructured":"Schubert, N., Schill, T., Pl\u00fc\u00df, M., and Korsten, P. (2020). Flare or foe?\u2014Mycobacterium marinum infection mimicking rheumatoid arthritis tenosynovitis: Case report and literature review. BMC Rheumatol., 4.","DOI":"10.1186\/s41927-020-0114-3"},{"key":"ref_114","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1086\/376628","article-title":"Fish Tank Exposure and Cutaneous Infections Due to Mycobacterium marinum: Tuberculin Skin Testing, Treatment, and Prevention","volume":"37","author":"Lewis","year":"2003","journal-title":"Clin. Infect. Dis."},{"key":"ref_115","doi-asserted-by":"crossref","first-page":"102391","DOI":"10.1016\/j.pdpdt.2021.102391","article-title":"The combination of photodynamic therapy and fractional CO2 laser for Mycobacterium marinum infection","volume":"35","author":"Wenlong","year":"2021","journal-title":"Photodiagn. Photodyn. Ther."},{"key":"ref_116","doi-asserted-by":"crossref","first-page":"669","DOI":"10.2147\/DDDT.S45197","article-title":"Mycobacterium marinum: A potential immunotherapy for Mycobacterium tuberculosis infection","volume":"7","author":"Tian","year":"2013","journal-title":"Drug Des. Dev. Ther."},{"key":"ref_117","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1111\/j.1365-2761.2009.01115.x","article-title":"Attenuated Mycobacterium marinum protects zebrafish against mycobacteriosis","volume":"33","author":"Cui","year":"2010","journal-title":"J. Fish Dis."},{"key":"ref_118","doi-asserted-by":"crossref","first-page":"1160","DOI":"10.3389\/fmicb.2018.01160","article-title":"Role of the Mycobacterium marinum ESX-1 Secretion System in Sliding Motility and Biofilm Formation","volume":"9","author":"Lai","year":"2018","journal-title":"Front. Microbiol."},{"key":"ref_119","doi-asserted-by":"crossref","first-page":"2752","DOI":"10.1016\/j.celrep.2017.02.057","article-title":"Recombinant BCG Expressing ESX-1 of Mycobacterium marinum Combines Low Virulence with Cytosolic Immune Signaling and Improved TB Protection","volume":"18","author":"Sayes","year":"2017","journal-title":"Cell Rep."},{"key":"ref_120","doi-asserted-by":"crossref","unstructured":"Johnson, P.D.R., Stinear, T., Small, P.L.C., Pluschke, G., Merritt, R.W., Portaels, F., Huygen, K., Hayman, J.A., and Asiedu, K. (2005). Buruli ulcer (M. ulcerans infection): New insights, new hope for disease control. PLoS Med., 2.","DOI":"10.1371\/journal.pmed.0020173"},{"key":"ref_121","doi-asserted-by":"crossref","unstructured":"Amissah, N.A., Glasner, C., Ablordey, A., Tetteh, C.S., Kotey, N.K., Prah, I., van der Werf, T., Rossen, J., Van Dijl, J.M., and Stienstra, Y. (2015). Genetic Diversity of Staphylococcus aureus in Buruli Ulcer. PLoS Negl. Trop. Dis., 9.","DOI":"10.1371\/journal.pntd.0003421"},{"key":"ref_122","first-page":"650","article-title":"The Pathogenic Behavior of Micobacterium Ulcerans and Mycobacterium Balnei in the Mouse and the Developing Chick Embryo","volume":"73","author":"Fenner","year":"1956","journal-title":"Am. Rev. Tuberc. Pulm. Dis."},{"key":"ref_123","doi-asserted-by":"crossref","first-page":"1395","DOI":"10.1084\/jem.20070234","article-title":"Selective suppression of dendritic cell functions by Mycobacterium ulcerans toxin mycolactone","volume":"204","author":"Coutanceau","year":"2007","journal-title":"J. Exp. Med."},{"key":"ref_124","doi-asserted-by":"crossref","unstructured":"Merritt, R.W., Walker, E.D., Small, P.L.C., Wallace, J.R., Johnson, P.D.R., Benbow, M.E., and Boakye, D.A. (2010). Ecology and Transmission of Buruli Ulcer Disease: A Systematic Review. PLoS Negl. Trop. Dis., 4.","DOI":"10.1371\/journal.pntd.0000911"},{"key":"ref_125","doi-asserted-by":"crossref","first-page":"2002","DOI":"10.1128\/IAI.01588-07","article-title":"Mycolactone is Responsible for the Painlessness of Mycobacterium ulcerans Infection (Buruli Ulcer) in a Murine Study","volume":"76","author":"En","year":"2008","journal-title":"Infect. Immun."},{"key":"ref_126","doi-asserted-by":"crossref","first-page":"1013","DOI":"10.1016\/S0140-6736(99)01156-3","article-title":"Mycobacterium ulcerans infection","volume":"354","author":"Tappero","year":"1999","journal-title":"Lancet"},{"key":"ref_127","doi-asserted-by":"crossref","unstructured":"Pluschke, G., and R\u00f6ltgen, K. (2019). Laboratory Diagnosis of Buruli Ulcer: Challenges and Future Perspectives. Buruli Ulcer: Mycobacterium Ulcerans Disease, Springer.","DOI":"10.1007\/978-3-030-11114-4"},{"key":"ref_128","doi-asserted-by":"crossref","first-page":"1345","DOI":"10.1073\/pnas.0305877101","article-title":"Giant plasmid-encoded polyketide synthases produce the macrolide toxin of Mycobacterium ulcerans","volume":"101","author":"Stinear","year":"2004","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_129","doi-asserted-by":"crossref","first-page":"654","DOI":"10.4161\/viru.22586","article-title":"The role of dendritic cells in Mycobacterium tuberculosis infection","volume":"3","author":"Mihret","year":"2012","journal-title":"Virulence"},{"key":"ref_130","doi-asserted-by":"crossref","first-page":"854","DOI":"10.1126\/science.283.5403.854","article-title":"Mycolactone: A Polyketide Toxin from Mycobacterium ulcerans Required for Virulence","volume":"283","author":"George","year":"1999","journal-title":"Science"},{"key":"ref_131","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1046\/j.1365-3156.2001.00746.x","article-title":"Susceptibility to development of Mycobacterium ulcerans disease: Review of possible risk factors","volume":"6","author":"Stienstra","year":"2001","journal-title":"Trop. Med. Int. Health"},{"key":"ref_132","doi-asserted-by":"crossref","unstructured":"Song, O.-R., Kim, H.-B., Jouny, S., Ricard, I., Vandeputte, A., Deboosere, N., Marion, E., Queval, C.J., Lesport, P., and Bourinet, E. (2017). A Bacterial Toxin with Analgesic Properties: Hyperpolarization of DRG Neurons by Mycolactone. Toxins, 9.","DOI":"10.3390\/toxins9070227"},{"key":"ref_133","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/j.ijmm.2017.04.002","article-title":"Virulence potential of Staphylococcus aureus isolates from Buruli ulcer patients","volume":"307","author":"Amissah","year":"2017","journal-title":"Int. J. Med. Microbiol."},{"key":"ref_134","doi-asserted-by":"crossref","first-page":"5310718","DOI":"10.1155\/2016\/5310718","article-title":"Clinical and Laboratory Diagnosis of Buruli Ulcer Disease: A Systematic Review","volume":"2016","author":"Sakyi","year":"2016","journal-title":"Can. J. Infect. Dis. Med. Microbiol."},{"key":"ref_135","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1111\/j.1365-3156.2006.01761.x","article-title":"A stepwise approach to the laboratory diagnosis of Buruli ulcer disease","volume":"12","author":"Bretzel","year":"2006","journal-title":"Trop. Med. Int. Health"},{"key":"ref_136","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1002\/path.1864","article-title":"Contiguous spread of Mycobacterium ulcerans in Buruli ulcer lesions analysed by histopathology and real-time PCR quantification of mycobacterial DNA","volume":"208","author":"Rondini","year":"2006","journal-title":"J. Pathol."},{"key":"ref_137","doi-asserted-by":"crossref","first-page":"1018","DOI":"10.1128\/JCM.37.4.1018-1023.1999","article-title":"Identification and characterization of IS2404 and IS2606: Two distinct repeated sequences for detection of Mycobacterium ulcerans by PCR","volume":"37","author":"Stinear","year":"1999","journal-title":"J. Clin. Microbiol."},{"key":"ref_138","doi-asserted-by":"crossref","first-page":"1185","DOI":"10.2217\/fmb.11.101","article-title":"Treating Mycobacterium ulcerans disease (Buruli ulcer): From surgery to antibiotics, is the pill mightier than the knife?","volume":"6","author":"Converse","year":"2011","journal-title":"Futur. Microbiol."},{"key":"ref_139","doi-asserted-by":"crossref","first-page":"664","DOI":"10.1016\/S0140-6736(09)61962-0","article-title":"Antimicrobial treatment for early, limited Mycobacterium ulcerans infection: A randomised controlled trial","volume":"375","author":"Nienhuis","year":"2010","journal-title":"Lancet"},{"key":"ref_140","doi-asserted-by":"crossref","first-page":"1259","DOI":"10.1016\/S0140-6736(20)30047-7","article-title":"Rifampicin and clarithromycin (extended release) versus rifampicin and streptomycin for limited Buruli ulcer lesions: A randomised, open-label, non-inferiority phase 3 trial","volume":"395","author":"Phillips","year":"2020","journal-title":"Lancet"},{"key":"ref_141","doi-asserted-by":"crossref","unstructured":"Frimpong, M., Agbavor, B., Duah, M.S., Loglo, A., Sarpong, F.N., Boakye-Appiah, J., Abass, K.M., Dongyele, M., Amofa, G., and Tuah, W. (2019). Paradoxical reactions in Buruli ulcer after initiation of antibiotic therapy: Relationship to bacterial load. PLoS Negl. Trop. Dis., 13.","DOI":"10.1371\/journal.pntd.0007689"},{"key":"ref_142","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1093\/cid\/cir856","article-title":"Paradoxical Responses After Start of Antimicrobial Treatment in Mycobacterium ulcerans Infection","volume":"54","author":"Nienhuis","year":"2011","journal-title":"Clin. Infect. Dis."},{"key":"ref_143","doi-asserted-by":"crossref","first-page":"e00753-19","DOI":"10.1128\/IAI.00753-19","article-title":"Vaccine-Specific Immune Responses against Mycobacterium ulcerans Infection in a Low-Dose Murine Challenge Model","volume":"88","author":"Mangas","year":"2020","journal-title":"Infect. Immun."},{"key":"ref_144","doi-asserted-by":"crossref","first-page":"7238","DOI":"10.1016\/j.vaccine.2021.05.092","article-title":"Systematic review of M. Bovis BCG and other candidate vaccines for Buruli ulcer prophylaxis","volume":"39","author":"Muhi","year":"2021","journal-title":"Vaccine"},{"key":"ref_145","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1016\/j.molimm.2020.02.009","article-title":"Structural basis and designing of peptide vaccine using PE-PGRS family protein of Mycobacterium ulcerans\u2014An integrated vaccinomics approach","volume":"120","author":"Nain","year":"2020","journal-title":"Mol. Immunol."},{"key":"ref_146","doi-asserted-by":"crossref","unstructured":"F\u00f6rster, B., Demangel, C., and Thye, T. (2020). Mycolactone induces cell death by SETD1B-dependent degradation of glutathione. PLoS Negl. Trop. Dis., 14.","DOI":"10.1371\/journal.pntd.0008709"},{"key":"ref_147","first-page":"1272","article-title":"Evaluation of the antibiotic properties of glutathione","volume":"12","author":"Schairer","year":"2013","journal-title":"J. Drugs Dermatol."},{"key":"ref_148","doi-asserted-by":"crossref","first-page":"1884","DOI":"10.1177\/15353702211015628","article-title":"Natural antioxidants attenuate mycolactone toxicity to RAW 264.7 macrophages","volume":"246","author":"Kwaffo","year":"2021","journal-title":"Exp. Biol. Med."},{"key":"ref_149","unstructured":"(2021, December 20). Fish Tank Granuloma\u2014American Osteopathic College\u2014AOCD. Available online: https:\/\/www.aocd.org\/general\/custom.asp?page=FishTankGranuloma."},{"key":"ref_150","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1016\/j.trivac.2016.04.001","article-title":"Immunogenicity and protection conferred by a recombinant Mycobacterium marinum vaccine against Buruli ulcer","volume":"5","author":"Hart","year":"2016","journal-title":"Trials Vaccinol."},{"key":"ref_151","unstructured":"World Health Organization (WHO) (2022, February 01). Treatment of Mycobacterium ulcerans disease (Buruli ulcer): Guidance for health workers. Available online: https:\/\/apps.who.int\/iris\/rest\/bitstreams\/109767\/retrieve."}],"container-title":["Vaccines"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2076-393X\/10\/3\/390\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T22:31:23Z","timestamp":1760135483000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2076-393X\/10\/3\/390"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,3,3]]},"references-count":151,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2022,3]]}},"alternative-id":["vaccines10030390"],"URL":"https:\/\/doi.org\/10.3390\/vaccines10030390","relation":{},"ISSN":["2076-393X"],"issn-type":[{"value":"2076-393X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,3,3]]}}}